aod9604 dosage protocol fat loss bodybuilding AOD 9604: The Ultimate Guide to Loss, Tissue Repair, and Metabolic Health AOD-9604 Dosage Guide: Complete Protocol
Description
In the SURMOUNT-1 trial, tirzepatide produced average weight loss of 15-22.5% of body weight over 72 weeks depending on dose
But fear not
It remains an investigational peptide, not an approved pharmaceutical
Looking forward to further results
